The effect of canine macrophages on the adherence and growth of Blastomyces dermatitidis yeast: Evidence of a soluble factor that enhances the growth of B. dermatitidis yeast

Microbial Pathogenesis

Volumn 27, Issue 6, 1999, Pages 395-405

  Giles, Steven ^a   Klein, Bruce ^a   Czuprynski, Charles ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Blastomyces dermatitidis; Canine; Growth; Macrophage; Yeast

Indexed keywords

COMPLEMENT;

ANIMAL CELL; ARTICLE; BLASTOMYCES DERMATITIDIS; BLASTOMYCOSIS; CELL ADHESION; CELL GROWTH; CELL PROLIFERATION; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FUNGUS GROWTH; MACROPHAGE; NONHUMAN; OPSONIZATION; PHAGOCYTE; PRIORITY JOURNAL; YEAST CELL;

AJELLOMYCES DERMATITIDIS; ANIMALIA; BLASTOMYCES; CANIS FAMILIARIS; FUNGI;

EID: 0033432794     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1999.0317     Document Type: Article

References (24)

1. Sarosi GA, Eckman MR, Davies SF, Laskey WK. Canine blastomycosis as a harbinger of human disease. Ann Intern Med. 91:1979;733-735.
2. Bloom JD, Hamor RE, Gerding PA. Ocular blastoÍmycosis in dogs - 73 cases, 108 eyes (1985-1993). J Amer Vet Med Assoc. 209:1996;1271-1274.
3. Buyukmihci N. Ocular lesions of blastomycosis in the dog. J Amer Vet Med Assoc. 180:1982;426-431.
4. Garma-Avina A. Cytologic findings in 43 cases of blastoÍmycosis diagnosed ante-mortem in naturally-infected dogs. Mycopathologia. 131:1995;87-91.
5. Brummer E, Stevens DA. Enhancing effect of murine polymorphonuclear neutrophils (PMN) on the multiplication of Blastomyces dermatitidis in vitro and in vivo. Clin Exper Immun. 54:1983;587-594.
6. Sarosi GA, Davies SF. Blastomycosis Review. Amer Rev Resp Dis. 120:1979;911-938.
7. Drutz D, Frey C. Intracellular and extracellular defenses of human phagocytes against Blastomyces dermatitidis conidia and yeast. J Lab Clin Med. 105:1985;737-750.
8. Zhang MSX, Klein B. Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis. Infect Immun. 65:1997;1849-1855.
9. Newman SL, Chaturvedi S, Klein BS. The Wi-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14. J Immunol. 154:1995;753-761.
10. Bradsher RW, Ulmer WC, Marmer DJ, Townsend JW, Jacobs RF. Intracellular growth and phagocytosis of Blastomyces dermatitidis by monocyte-derived macrophages from previously infected and normal subjects. J Infect Dis. 151:1985;57-64.
11. Bradsher RW, Balk RA, Jacobs RF. Growth inhibition of Blastomyces dermatitidis in alveolar and peripheral macrophages from patients with blastomycosis. Amer Rev Resp Dis. 135:1987;412-417.
12. Calich VL, Kipnis TL, Mariano M, Neto CF, Dias da Silva WD. The activation of the complement system by Paracoccidioides brasiliensis in vitro: its opsonic effect and possible significance for an in vivo model of infection. Clin Immunol Immunopatol. 12:1979;21-30.
13. Hector RF, Yee E, Collins MS. Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis. Infect Immun. 58:1990;1476-1478.
14. Lovchik JA, Lipscomb MF. Role for C5 and neutrophils in the pulmonary intravascular clearance of circulating Cryptococcus neoformans. Amer J Respir Cell Molec Biol. 9:1993;617-627.
15. Winkelstein, JA, Ameratunga, R, Handbook of Vertebrate Immunology, 274-275, 1998. Academic Press, London, England.
16. Polhill RB, Newman SL, Pruitt KM, Johnston RB. Kinetic assessment of alternative complement pathway activity in a hemolytic system. II. Influence of antibody on alternative pathway activation. J Immunol. 121:1978;371-376.
17. Lint TF, Behrends CL, Baker PJ, Gewurz H. Activation of the complement attack mechanism in the fluid phase and its control by C567-INH: lysis of normal erythroÍcytes initiated by zymosan, endotoxin, and immune complexes. J Immunol. 117:1976;1440-1446.
18. Zhang MX, Lupan DM, Kozel TR. Mannan-specific immunoglobulin G antibodies in normal human serum mediate classical pathway initiation of C3 binding toCandida albicans. Infect Immun. 65:1997;3822-3827.
19. Zhang MSX, Kozel TR. Mannan-specific immunoglobulin G antibodies in normal human serum accelerate binding of C3 to Candida albicans via the alternative complement pathway. Infect Immun. 66:1998;4845-4850.
20. Wilson MA, Kozel TR. Contribution of antibody in normal human serum to early deposition of C3 onto encapsulated and nonencapsulatedCryptococcus neoformans. Infect Immun. 60:1992;754-761.
21. Soderstrom BE. Vital staining of fungi in pure cultures and in soil with fluorescein diacetate. Soil Biol Biochem. 9:1977;59-63.
22. Iqbal A, Rikihisa Y. Reisolation of Ehrlichia canis from blood and tissues of dogs after doxycycline treatment. J Clin Microb. 32:1994;1644-1649.
23. Ameratunga RJA, Winkelstein JA, Brody L, Binns M, Cork LC, Colombani P, Valle D. Molecular analysis of the third component of canine complement (C3) and identification of the mutation responsible for hereditary canine C3 deficiency. J Immun. 160:1998;2824-2830.
24. Mayer, M, Complement vs. complement fixation, In: ««Experimental Immunochemistry»», 2nd ed. (EA Kabat and MM Mayer, eds) 133-239. 1961, Thomas, Springfield, IL.